sodium,(2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-[2-(pyridine-4-carbonyl)hydrazinyl]oxane-2-carboxylate

Names

[ CAS No. ]:
59470-49-4

[ Name ]:
sodium,(2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-[2-(pyridine-4-carbonyl)hydrazinyl]oxane-2-carboxylate

Chemical & Physical Properties

[ Boiling Point ]:
606.5ºC at 760 mmHg

[ Molecular Formula ]:
C12H14N3NaO7

[ Molecular Weight ]:
335.24500

[ Flash Point ]:
320.6ºC

[ Exact Mass ]:
335.07300

[ PSA ]:
164.07000

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
LZ6572650
CHEMICAL NAME :
Glucopyranuronic acid, 2-(2-isonicotinoylhydrazino)-, D-, sodium salt, dihydrate
CAS REGISTRY NUMBER :
59470-49-4
LAST UPDATED :
199712
DATA ITEMS CITED :
5
MOLECULAR FORMULA :
C12-H14-N3-O7.Na.2H2-O
MOLECULAR WEIGHT :
371.32

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
20325 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 26,409,1976
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
8537 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 26,409,1976
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1309 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 26,409,1976
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
5827 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 26,409,1976
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
1792 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 26,409,1976

Related Compounds

  • Tert-butyl 4-{3-azido-5-[(chlorosulfonyl)methyl]-2-methylphenyl}piperazine-1-carboxylate
  • tert-butyl 4-{3-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]-2,4,6-trimethyl-5-[2-(trimethylsilyl)ethynyl]phenyl}piperazine-1-carboxylate
  • tert-butyl 4-{[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-2,4,6-trimethyl-5-[2-(trimethylsilyl)ethynyl]phenyl]methyl}piperazine-1-carboxylate
  • (9H-fluoren-9-yl)methyl 4-[(3-{[(tert-butoxy)carbonyl]amino}-2,4,6-trimethyl-5-[2-(trimethylsilyl)ethynyl]phenyl)methyl]piperazine-1-carboxylate
  • tert-butyl N-[2-(6-hydroxypyridin-3-yl)ethyl]carbamate
  • (9H-fluoren-9-yl)methyl 4-{3-[(tert-butoxy)carbonyl]-5-iodo-2,4,6-trimethylphenyl}piperazine-1-carboxylate
  • Tert-butyl 3-(4-hydroxypyrimidin-2-yl)azetidine-1-carboxylate
  • tert-butyl 7-hydroxy-5-oxo-1H,2H,3H,5H-imidazo[1,2-a]pyrimidine-1-carboxylate
  • tert-butyl N-cyclohexyl-N-[(4-hydroxyphenyl)methyl]carbamate
  • tert-butyl 4-{[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-5-[(fluorosulfonyl)oxy]-2,4,6-trimethylphenyl]methyl}piperazine-1-carboxylate
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.